Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
S.GoreckiA
Therapeutic strategy focusing on the ferroptosis pathway SLC7A11, a molecule that protects cancer cells from ferroptosis-induced cell death, is overexpressed in different types of cancers, including ovarian cancer, lung cancer, triple-negative breast cancer, PDAC, renal cell carcinoma, liver cancer, and glioma, and it is associated with aggressive phenotypes and poor prognosis [16,46,89]
Its sterile, pH-balanced formulation ensures minimal cytotoxicity and maintains redox integrity, making it uniquely suited for high-resolution studies of antioxidant defenses, phase-II enzyme kinetics, and inflammation-resolution pathways in both cell-culture and animal models
Get In Touch Have questions about Epithalon products or research-use details
However, no formal drug interaction studies have been conducted
US$ 20.27
US$ 21.73
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 19.98
